The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[1-[4-(morpholine-4-carbonyl)-2-phenyl-1H-imidazol-5-yl]-7-oxo-nonyl]thiazole-5-carboxamide ID: ALA4793558
PubChem CID: 162673504
Max Phase: Preclinical
Molecular Formula: C27H33N5O4S
Molecular Weight: 523.66
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCC(=O)CCCCCC(NC(=O)c1cncs1)c1[nH]c(-c2ccccc2)nc1C(=O)N1CCOCC1
Standard InChI: InChI=1S/C27H33N5O4S/c1-2-20(33)11-7-4-8-12-21(29-26(34)22-17-28-18-37-22)23-24(27(35)32-13-15-36-16-14-32)31-25(30-23)19-9-5-3-6-10-19/h3,5-6,9-10,17-18,21H,2,4,7-8,11-16H2,1H3,(H,29,34)(H,30,31)
Standard InChI Key: WWUHRAHHBCTRRW-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
2.1046 -14.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1035 -15.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8188 -16.0259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5358 -15.6105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5330 -14.7800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8171 -14.3729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2400 -14.3686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9954 -14.6996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5464 -14.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1333 -13.3740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3270 -13.5478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3673 -14.1702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7081 -14.9230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8514 -13.5002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4643 -12.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2844 -12.5297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9751 -11.9523 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6722 -13.5829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1522 -12.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9730 -12.9956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4571 -12.3256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2780 -12.4124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7579 -11.7424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6147 -13.1610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5788 -11.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5289 -15.0058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8656 -15.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0089 -14.3357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4510 -16.4678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0067 -17.0799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7596 -16.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6705 -15.9231 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.7685 -13.1951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5853 -13.1085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9203 -12.3545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4322 -11.6904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6090 -11.7760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
5 7 1 0
9 12 1 0
12 13 1 0
12 14 1 0
10 15 1 0
15 16 1 0
15 17 2 0
14 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 24 2 0
23 25 1 0
13 26 1 0
26 27 1 0
26 28 2 0
27 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 27 1 0
16 33 1 0
16 37 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 523.66Molecular Weight (Monoisotopic): 523.2253AlogP: 4.41#Rotatable Bonds: 12Polar Surface Area: 117.28Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.20CX Basic pKa: 2.73CX LogP: 3.28CX LogD: 3.28Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.34Np Likeness Score: -0.84
References 1. Clausen DJ,Liu J,Yu W,Duffy JL,Chung CC,Myers RW,Klein DJ,Fells J,Holloway K,Wu J,Wu G,Howell BJ,Barnard RJO,Kozlowski J. (2020) Development of a selective HDAC inhibitor aimed at reactivating the HIV latent reservoir., 30 (17.0): [PMID:32738976 ] [10.1016/j.bmcl.2020.127367 ]